Drug profile

The FDA adverse-event record for Vitamin C

53 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Vitamin C. Species, reactions, and outcomes follow.

#1086 of 2,679
by report volume (all drugs)
53
adverse-event reports
15.1%
death-coded share
Dog
most-reported species

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Vitamin C ranks #1077 of 2679 by total reports (53) and #359 of 1130 by death-coded share (15.1%). National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1077
This drug, reports of 2679
#359
This drug, death share of 1130

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Vitamin C has 53 reports now versus 51 in that prior snapshot: 2 more (3.9%).

Report change
+2
Death-coded reports
+1
Death-coded share
+1.4 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Vitamin C changes

Signature read: death-coded share at 15.1% is the most distinctive stamp on Vitamin C's FDA AER row.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
53
Total Reports
8
Deaths Reported
15.1%
Death-coded share of reports

Active Ingredients

Vitamin C

Administration Routes

OralUnknownSubcutaneousIntravenous

Species Affected

Dog 44
Human 5
Cat 4

Most Affected Breeds

Retriever - Labrador 9
Unknown 5
Domestic Shorthair 3
Spaniel (unspecified) 2
Dog (unknown) 2
Spitz - German Pomeranian 2
Retriever - Golden 2
Poodle - Standard 2
Shepherd Dog - German 2
Shepherd Dog - Australian 2

Most Reported Reactions

Vomiting 12
Lethargy (see also Central nervous system depression in 'Neurological') 9
Emesis 6
Diarrhoea 6
Elevated liver enzymes 6
Other abnormal test result NOS 5
Anorexia 5
Depression 5
Not eating 4
Elevated blood urea nitrogen (BUN) 4
Death 4
Dehydration 4

Outcome Breakdown

Recovered/Normal
20 (37.7%)
Outcome Unknown
17 (32.1%)
Ongoing
6 (11.3%)
Died
5 (9.4%)
Euthanized
3 (5.7%)
Recovered with Sequela
2 (3.8%)

Vitamin C Adverse Event Insights

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Nationwide drugs with similar profiles

Two openFDA-derived peer sets for Vitamin C, both floored at ≥50 reports so the neighborhoods stay in the advertised mass.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Vitamin C (#1086 of 2,679 by report volume); death-coded 15.1%. PlainBreed drug row · death-coded share stamp 15.1% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →